Chart, page-5539

lots of excellent speculation there

I made an earlier comment somewhere on HC that high risk unique companies have a profile that increasingly investors will turn to in a high inflation environment. Put simply , if you want growth in the portfolio going forward you have to start increasing risk profile. Im seeing this happening now in all my biotech , incl ( finally ) ANP.

Volume and price is only going one way. Investors starting to pour back in.

I am as certain as I can be that ANP is coming back because of this. If I wasnt already ballsdeep across the biotech sector I would be pouring more money in right now. ANP is my 2nd largest biotech play.

I would suggest that NOW is a good time to stop looking backwards and just enjoy what the next 12 months brings

GLA

Of course I could be completely and utterly wrong and no-one should take any notice of me ..... Im just a happy investor